nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—prostate cancer—testicular cancer	0.599	1	CtDrD
Prednisone—SLCO1A2—Chlorambucil—testicular cancer	0.134	0.469	CbGbCtD
Prednisone—CYP2C19—Ifosfamide—testicular cancer	0.0254	0.0891	CbGbCtD
Prednisone—SLCO1A2—Methotrexate—testicular cancer	0.024	0.084	CbGbCtD
Prednisone—ABCB1—Dactinomycin—testicular cancer	0.0174	0.0609	CbGbCtD
Prednisone—ALB—Methotrexate—testicular cancer	0.0124	0.0434	CbGbCtD
Prednisone—CYP3A4—Ifosfamide—testicular cancer	0.0123	0.0431	CbGbCtD
Prednisone—ABCB1—Vinblastine—testicular cancer	0.0109	0.0381	CbGbCtD
Prednisone—ABCB1—Cisplatin—testicular cancer	0.00999	0.035	CbGbCtD
Prednisone—ABCB1—Etoposide—testicular cancer	0.00981	0.0343	CbGbCtD
Prednisone—ABCB1—Doxorubicin—testicular cancer	0.00669	0.0234	CbGbCtD
Prednisone—CYP3A4—Vinblastine—testicular cancer	0.00653	0.0228	CbGbCtD
Prednisone—ABCB1—Methotrexate—testicular cancer	0.00648	0.0227	CbGbCtD
Prednisone—CYP3A4—Etoposide—testicular cancer	0.00588	0.0206	CbGbCtD
Prednisone—CYP3A4—Doxorubicin—testicular cancer	0.00401	0.014	CbGbCtD
Prednisone—HSD11B1—seminal vesicle—testicular cancer	0.00264	0.205	CbGeAlD
Prednisone—HSD11B1—gonad—testicular cancer	0.00191	0.148	CbGeAlD
Prednisone—HSD11B1—female gonad—testicular cancer	0.00155	0.12	CbGeAlD
Prednisone—HSD11B1—testis—testicular cancer	0.00138	0.107	CbGeAlD
Prednisone—HSD11B1—lymph node—testicular cancer	0.000997	0.0774	CbGeAlD
Prednisone—NR3C1—embryo—testicular cancer	0.000532	0.0413	CbGeAlD
Prednisone—NR3C1—seminal vesicle—testicular cancer	0.0005	0.0388	CbGeAlD
Prednisone—SLCO1A2—testis—testicular cancer	0.000416	0.0323	CbGeAlD
Prednisone—ALB—testis—testicular cancer	0.000414	0.0321	CbGeAlD
Prednisone—NR3C1—gonad—testicular cancer	0.000361	0.028	CbGeAlD
Prednisone—ALB—lymph node—testicular cancer	0.0003	0.0233	CbGeAlD
Prednisone—NR3C1—female gonad—testicular cancer	0.000294	0.0228	CbGeAlD
Prednisone—ABCB1—embryo—testicular cancer	0.000285	0.0221	CbGeAlD
Prednisone—ABCB1—seminal vesicle—testicular cancer	0.000268	0.0208	CbGeAlD
Prednisone—NR3C1—testis—testicular cancer	0.00026	0.0202	CbGeAlD
Prednisone—ABCB1—gonad—testicular cancer	0.000193	0.015	CbGeAlD
Prednisone—NR3C1—lymph node—testicular cancer	0.000189	0.0147	CbGeAlD
Prednisone—ABCB1—female gonad—testicular cancer	0.000157	0.0122	CbGeAlD
Prednisone—ABCB1—testis—testicular cancer	0.000139	0.0108	CbGeAlD
Prednisone—ABCB1—lymph node—testicular cancer	0.000101	0.00784	CbGeAlD
Prednisone—Discomfort—Etoposide—testicular cancer	9.03e-05	0.000887	CcSEcCtD
Prednisone—Face oedema—Doxorubicin—testicular cancer	8.93e-05	0.000877	CcSEcCtD
Prednisone—Hypersensitivity—Dactinomycin—testicular cancer	8.92e-05	0.000876	CcSEcCtD
Prednisone—Muscular weakness—Epirubicin—testicular cancer	8.82e-05	0.000866	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Epirubicin—testicular cancer	8.82e-05	0.000866	CcSEcCtD
Prednisone—Urticaria—Ifosfamide—testicular cancer	8.82e-05	0.000866	CcSEcCtD
Prednisone—Cardiac arrest—Doxorubicin—testicular cancer	8.8e-05	0.000864	CcSEcCtD
Prednisone—Abdominal pain—Ifosfamide—testicular cancer	8.77e-05	0.000861	CcSEcCtD
Prednisone—Body temperature increased—Ifosfamide—testicular cancer	8.77e-05	0.000861	CcSEcCtD
Prednisone—Anaphylactic shock—Etoposide—testicular cancer	8.77e-05	0.000861	CcSEcCtD
Prednisone—Mood swings—Doxorubicin—testicular cancer	8.76e-05	0.00086	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Cisplatin—testicular cancer	8.72e-05	0.000856	CcSEcCtD
Prednisone—Infection—Etoposide—testicular cancer	8.71e-05	0.000855	CcSEcCtD
Prednisone—Abdominal distension—Epirubicin—testicular cancer	8.7e-05	0.000854	CcSEcCtD
Prednisone—Asthenia—Dactinomycin—testicular cancer	8.69e-05	0.000853	CcSEcCtD
Prednisone—Neutropenia—Methotrexate—testicular cancer	8.63e-05	0.000848	CcSEcCtD
Prednisone—Paraesthesia—Cisplatin—testicular cancer	8.59e-05	0.000843	CcSEcCtD
Prednisone—Tachycardia—Etoposide—testicular cancer	8.56e-05	0.00084	CcSEcCtD
Prednisone—Skin disorder—Etoposide—testicular cancer	8.51e-05	0.000836	CcSEcCtD
Prednisone—Erectile dysfunction—Methotrexate—testicular cancer	8.5e-05	0.000835	CcSEcCtD
Prednisone—Dry skin—Doxorubicin—testicular cancer	8.48e-05	0.000832	CcSEcCtD
Prednisone—Hyperhidrosis—Etoposide—testicular cancer	8.47e-05	0.000832	CcSEcCtD
Prednisone—Pancreatitis—Epirubicin—testicular cancer	8.47e-05	0.000832	CcSEcCtD
Prednisone—Hypokalaemia—Doxorubicin—testicular cancer	8.42e-05	0.000826	CcSEcCtD
Prednisone—Anorexia—Etoposide—testicular cancer	8.36e-05	0.00082	CcSEcCtD
Prednisone—Decreased appetite—Cisplatin—testicular cancer	8.32e-05	0.000817	CcSEcCtD
Prednisone—Diarrhoea—Dactinomycin—testicular cancer	8.29e-05	0.000814	CcSEcCtD
Prednisone—Vomiting—Bleomycin—testicular cancer	8.26e-05	0.000811	CcSEcCtD
Prednisone—Depression—Methotrexate—testicular cancer	8.21e-05	0.000806	CcSEcCtD
Prednisone—Rash—Bleomycin—testicular cancer	8.19e-05	0.000804	CcSEcCtD
Prednisone—Dermatitis—Bleomycin—testicular cancer	8.18e-05	0.000803	CcSEcCtD
Prednisone—Hypersensitivity—Ifosfamide—testicular cancer	8.18e-05	0.000803	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Doxorubicin—testicular cancer	8.16e-05	0.000801	CcSEcCtD
Prednisone—Muscular weakness—Doxorubicin—testicular cancer	8.16e-05	0.000801	CcSEcCtD
Prednisone—Neutropenia—Epirubicin—testicular cancer	8.08e-05	0.000793	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—testicular cancer	8.05e-05	0.00079	CcSEcCtD
Prednisone—Asthenia—Ifosfamide—testicular cancer	7.96e-05	0.000782	CcSEcCtD
Prednisone—Feeling abnormal—Cisplatin—testicular cancer	7.89e-05	0.000774	CcSEcCtD
Prednisone—Paraesthesia—Etoposide—testicular cancer	7.87e-05	0.000773	CcSEcCtD
Prednisone—Weight increased—Epirubicin—testicular cancer	7.86e-05	0.000772	CcSEcCtD
Prednisone—Pruritus—Ifosfamide—testicular cancer	7.85e-05	0.000771	CcSEcCtD
Prednisone—Pancreatitis—Doxorubicin—testicular cancer	7.84e-05	0.00077	CcSEcCtD
Prednisone—Weight decreased—Epirubicin—testicular cancer	7.82e-05	0.000767	CcSEcCtD
Prednisone—Hyperglycaemia—Epirubicin—testicular cancer	7.79e-05	0.000765	CcSEcCtD
Prednisone—Nausea—Bleomycin—testicular cancer	7.71e-05	0.000757	CcSEcCtD
Prednisone—Vomiting—Dactinomycin—testicular cancer	7.7e-05	0.000756	CcSEcCtD
Prednisone—Rash—Dactinomycin—testicular cancer	7.64e-05	0.00075	CcSEcCtD
Prednisone—Decreased appetite—Etoposide—testicular cancer	7.62e-05	0.000748	CcSEcCtD
Prednisone—Diarrhoea—Ifosfamide—testicular cancer	7.59e-05	0.000745	CcSEcCtD
Prednisone—Body temperature increased—Cisplatin—testicular cancer	7.56e-05	0.000743	CcSEcCtD
Prednisone—Fatigue—Etoposide—testicular cancer	7.56e-05	0.000742	CcSEcCtD
Prednisone—Neuropathy peripheral—Epirubicin—testicular cancer	7.55e-05	0.000741	CcSEcCtD
Prednisone—Constipation—Etoposide—testicular cancer	7.5e-05	0.000736	CcSEcCtD
Prednisone—Neutropenia—Doxorubicin—testicular cancer	7.48e-05	0.000734	CcSEcCtD
Prednisone—Haemoglobin—Methotrexate—testicular cancer	7.43e-05	0.000729	CcSEcCtD
Prednisone—Haemorrhage—Methotrexate—testicular cancer	7.39e-05	0.000726	CcSEcCtD
Prednisone—Dizziness—Ifosfamide—testicular cancer	7.34e-05	0.000721	CcSEcCtD
Prednisone—Weight increased—Doxorubicin—testicular cancer	7.28e-05	0.000714	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—testicular cancer	7.23e-05	0.00071	CcSEcCtD
Prednisone—Feeling abnormal—Etoposide—testicular cancer	7.22e-05	0.000709	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—testicular cancer	7.21e-05	0.000708	CcSEcCtD
Prednisone—Nausea—Dactinomycin—testicular cancer	7.19e-05	0.000706	CcSEcCtD
Prednisone—Gastrointestinal pain—Etoposide—testicular cancer	7.17e-05	0.000704	CcSEcCtD
Prednisone—Vomiting—Ifosfamide—testicular cancer	7.06e-05	0.000693	CcSEcCtD
Prednisone—Hypersensitivity—Cisplatin—testicular cancer	7.05e-05	0.000692	CcSEcCtD
Prednisone—Bradycardia—Epirubicin—testicular cancer	7.04e-05	0.000691	CcSEcCtD
Prednisone—Rash—Ifosfamide—testicular cancer	7e-05	0.000687	CcSEcCtD
Prednisone—Dermatitis—Ifosfamide—testicular cancer	6.99e-05	0.000686	CcSEcCtD
Prednisone—Neuropathy peripheral—Doxorubicin—testicular cancer	6.99e-05	0.000686	CcSEcCtD
Prednisone—Urticaria—Etoposide—testicular cancer	6.96e-05	0.000684	CcSEcCtD
Prednisone—Haemoglobin—Epirubicin—testicular cancer	6.95e-05	0.000682	CcSEcCtD
Prednisone—Abdominal pain—Etoposide—testicular cancer	6.93e-05	0.00068	CcSEcCtD
Prednisone—Body temperature increased—Etoposide—testicular cancer	6.93e-05	0.00068	CcSEcCtD
Prednisone—Haemorrhage—Epirubicin—testicular cancer	6.92e-05	0.000679	CcSEcCtD
Prednisone—Eye disorder—Methotrexate—testicular cancer	6.91e-05	0.000678	CcSEcCtD
Prednisone—Asthenia—Cisplatin—testicular cancer	6.87e-05	0.000674	CcSEcCtD
Prednisone—Connective tissue disorder—Epirubicin—testicular cancer	6.8e-05	0.000667	CcSEcCtD
Prednisone—Angiopathy—Methotrexate—testicular cancer	6.71e-05	0.000658	CcSEcCtD
Prednisone—Immune system disorder—Methotrexate—testicular cancer	6.68e-05	0.000655	CcSEcCtD
Prednisone—Nausea—Ifosfamide—testicular cancer	6.59e-05	0.000647	CcSEcCtD
Prednisone—Diarrhoea—Cisplatin—testicular cancer	6.55e-05	0.000643	CcSEcCtD
Prednisone—Alopecia—Methotrexate—testicular cancer	6.53e-05	0.000641	CcSEcCtD
Prednisone—Bradycardia—Doxorubicin—testicular cancer	6.52e-05	0.00064	CcSEcCtD
Prednisone—Mental disorder—Methotrexate—testicular cancer	6.48e-05	0.000636	CcSEcCtD
Prednisone—Eye disorder—Epirubicin—testicular cancer	6.46e-05	0.000635	CcSEcCtD
Prednisone—Hypersensitivity—Etoposide—testicular cancer	6.46e-05	0.000634	CcSEcCtD
Prednisone—Malnutrition—Methotrexate—testicular cancer	6.43e-05	0.000632	CcSEcCtD
Prednisone—Erythema—Methotrexate—testicular cancer	6.43e-05	0.000632	CcSEcCtD
Prednisone—Haemoglobin—Doxorubicin—testicular cancer	6.43e-05	0.000631	CcSEcCtD
Prednisone—Flushing—Epirubicin—testicular cancer	6.42e-05	0.00063	CcSEcCtD
Prednisone—Haemorrhage—Doxorubicin—testicular cancer	6.4e-05	0.000628	CcSEcCtD
Prednisone—Asthenia—Etoposide—testicular cancer	6.29e-05	0.000617	CcSEcCtD
Prednisone—Connective tissue disorder—Doxorubicin—testicular cancer	6.29e-05	0.000617	CcSEcCtD
Prednisone—Angiopathy—Epirubicin—testicular cancer	6.28e-05	0.000616	CcSEcCtD
Prednisone—Immune system disorder—Epirubicin—testicular cancer	6.25e-05	0.000613	CcSEcCtD
Prednisone—Pruritus—Etoposide—testicular cancer	6.2e-05	0.000609	CcSEcCtD
Prednisone—Arrhythmia—Epirubicin—testicular cancer	6.18e-05	0.000607	CcSEcCtD
Prednisone—Alopecia—Epirubicin—testicular cancer	6.11e-05	0.0006	CcSEcCtD
Prednisone—Vomiting—Cisplatin—testicular cancer	6.08e-05	0.000597	CcSEcCtD
Prednisone—Vision blurred—Methotrexate—testicular cancer	6.06e-05	0.000595	CcSEcCtD
Prednisone—Mental disorder—Epirubicin—testicular cancer	6.06e-05	0.000595	CcSEcCtD
Prednisone—Rash—Cisplatin—testicular cancer	6.03e-05	0.000592	CcSEcCtD
Prednisone—Dermatitis—Cisplatin—testicular cancer	6.03e-05	0.000592	CcSEcCtD
Prednisone—Erythema—Epirubicin—testicular cancer	6.02e-05	0.000591	CcSEcCtD
Prednisone—Malnutrition—Epirubicin—testicular cancer	6.02e-05	0.000591	CcSEcCtD
Prednisone—Diarrhoea—Etoposide—testicular cancer	6e-05	0.000589	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—testicular cancer	5.98e-05	0.000587	CcSEcCtD
Prednisone—Ill-defined disorder—Methotrexate—testicular cancer	5.97e-05	0.000586	CcSEcCtD
Prednisone—Anaemia—Methotrexate—testicular cancer	5.95e-05	0.000584	CcSEcCtD
Prednisone—Flushing—Doxorubicin—testicular cancer	5.94e-05	0.000583	CcSEcCtD
Prednisone—Angiopathy—Doxorubicin—testicular cancer	5.81e-05	0.00057	CcSEcCtD
Prednisone—Malaise—Methotrexate—testicular cancer	5.8e-05	0.00057	CcSEcCtD
Prednisone—Dizziness—Etoposide—testicular cancer	5.8e-05	0.000569	CcSEcCtD
Prednisone—Immune system disorder—Doxorubicin—testicular cancer	5.78e-05	0.000567	CcSEcCtD
Prednisone—Vertigo—Methotrexate—testicular cancer	5.78e-05	0.000567	CcSEcCtD
Prednisone—Arrhythmia—Doxorubicin—testicular cancer	5.72e-05	0.000561	CcSEcCtD
Prednisone—Nausea—Cisplatin—testicular cancer	5.68e-05	0.000558	CcSEcCtD
Prednisone—Vision blurred—Epirubicin—testicular cancer	5.67e-05	0.000557	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—testicular cancer	5.66e-05	0.000555	CcSEcCtD
Prednisone—Mental disorder—Doxorubicin—testicular cancer	5.61e-05	0.00055	CcSEcCtD
Prednisone—Ill-defined disorder—Epirubicin—testicular cancer	5.59e-05	0.000548	CcSEcCtD
Prednisone—Convulsion—Methotrexate—testicular cancer	5.57e-05	0.000547	CcSEcCtD
Prednisone—Vomiting—Etoposide—testicular cancer	5.57e-05	0.000547	CcSEcCtD
Prednisone—Erythema—Doxorubicin—testicular cancer	5.57e-05	0.000547	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—testicular cancer	5.57e-05	0.000547	CcSEcCtD
Prednisone—Anaemia—Epirubicin—testicular cancer	5.56e-05	0.000546	CcSEcCtD
Prednisone—Agitation—Epirubicin—testicular cancer	5.53e-05	0.000543	CcSEcCtD
Prednisone—Rash—Etoposide—testicular cancer	5.53e-05	0.000543	CcSEcCtD
Prednisone—Dermatitis—Etoposide—testicular cancer	5.52e-05	0.000542	CcSEcCtD
Prednisone—Headache—Etoposide—testicular cancer	5.49e-05	0.000539	CcSEcCtD
Prednisone—Arthralgia—Methotrexate—testicular cancer	5.48e-05	0.000538	CcSEcCtD
Prednisone—Myalgia—Methotrexate—testicular cancer	5.48e-05	0.000538	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	5.44e-05	0.000534	CcSEcCtD
Prednisone—Malaise—Epirubicin—testicular cancer	5.43e-05	0.000533	CcSEcCtD
Prednisone—Discomfort—Methotrexate—testicular cancer	5.41e-05	0.000531	CcSEcCtD
Prednisone—Vertigo—Epirubicin—testicular cancer	5.41e-05	0.000531	CcSEcCtD
Prednisone—Syncope—Epirubicin—testicular cancer	5.4e-05	0.00053	CcSEcCtD
Prednisone—Loss of consciousness—Epirubicin—testicular cancer	5.29e-05	0.000519	CcSEcCtD
Prednisone—Anaphylactic shock—Methotrexate—testicular cancer	5.25e-05	0.000515	CcSEcCtD
Prednisone—Vision blurred—Doxorubicin—testicular cancer	5.25e-05	0.000515	CcSEcCtD
Prednisone—Convulsion—Epirubicin—testicular cancer	5.22e-05	0.000512	CcSEcCtD
Prednisone—Infection—Methotrexate—testicular cancer	5.22e-05	0.000512	CcSEcCtD
Prednisone—Nausea—Etoposide—testicular cancer	5.21e-05	0.000511	CcSEcCtD
Prednisone—Hypertension—Epirubicin—testicular cancer	5.2e-05	0.00051	CcSEcCtD
Prednisone—Ill-defined disorder—Doxorubicin—testicular cancer	5.17e-05	0.000507	CcSEcCtD
Prednisone—Nervous system disorder—Methotrexate—testicular cancer	5.15e-05	0.000505	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—testicular cancer	5.15e-05	0.000505	CcSEcCtD
Prednisone—Arthralgia—Epirubicin—testicular cancer	5.13e-05	0.000503	CcSEcCtD
Prednisone—Myalgia—Epirubicin—testicular cancer	5.13e-05	0.000503	CcSEcCtD
Prednisone—Agitation—Doxorubicin—testicular cancer	5.12e-05	0.000503	CcSEcCtD
Prednisone—Anxiety—Epirubicin—testicular cancer	5.11e-05	0.000501	CcSEcCtD
Prednisone—Skin disorder—Methotrexate—testicular cancer	5.1e-05	0.000501	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	5.09e-05	0.0005	CcSEcCtD
Prednisone—Hyperhidrosis—Methotrexate—testicular cancer	5.08e-05	0.000498	CcSEcCtD
Prednisone—Discomfort—Epirubicin—testicular cancer	5.06e-05	0.000497	CcSEcCtD
Prednisone—Malaise—Doxorubicin—testicular cancer	5.02e-05	0.000493	CcSEcCtD
Prednisone—Vertigo—Doxorubicin—testicular cancer	5.01e-05	0.000491	CcSEcCtD
Prednisone—Anorexia—Methotrexate—testicular cancer	5.01e-05	0.000491	CcSEcCtD
Prednisone—Syncope—Doxorubicin—testicular cancer	5e-05	0.00049	CcSEcCtD
Prednisone—Oedema—Epirubicin—testicular cancer	4.91e-05	0.000482	CcSEcCtD
Prednisone—Anaphylactic shock—Epirubicin—testicular cancer	4.91e-05	0.000482	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—testicular cancer	4.9e-05	0.000481	CcSEcCtD
Prednisone—Infection—Epirubicin—testicular cancer	4.88e-05	0.000479	CcSEcCtD
Prednisone—Shock—Epirubicin—testicular cancer	4.83e-05	0.000475	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—testicular cancer	4.83e-05	0.000474	CcSEcCtD
Prednisone—Nervous system disorder—Epirubicin—testicular cancer	4.82e-05	0.000473	CcSEcCtD
Prednisone—Hypertension—Doxorubicin—testicular cancer	4.81e-05	0.000472	CcSEcCtD
Prednisone—Tachycardia—Epirubicin—testicular cancer	4.8e-05	0.000471	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Methotrexate—testicular cancer	4.78e-05	0.00047	CcSEcCtD
Prednisone—Skin disorder—Epirubicin—testicular cancer	4.77e-05	0.000469	CcSEcCtD
Prednisone—Hyperhidrosis—Epirubicin—testicular cancer	4.75e-05	0.000466	CcSEcCtD
Prednisone—Insomnia—Methotrexate—testicular cancer	4.75e-05	0.000466	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—testicular cancer	4.74e-05	0.000466	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—testicular cancer	4.74e-05	0.000466	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—testicular cancer	4.73e-05	0.000464	CcSEcCtD
Prednisone—Paraesthesia—Methotrexate—testicular cancer	4.71e-05	0.000463	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	4.71e-05	0.000462	CcSEcCtD
Prednisone—Discomfort—Doxorubicin—testicular cancer	4.69e-05	0.00046	CcSEcCtD
Prednisone—Anorexia—Epirubicin—testicular cancer	4.68e-05	0.00046	CcSEcCtD
Prednisone—Dyspepsia—Methotrexate—testicular cancer	4.62e-05	0.000454	CcSEcCtD
Prednisone—Decreased appetite—Methotrexate—testicular cancer	4.56e-05	0.000448	CcSEcCtD
Prednisone—Anaphylactic shock—Doxorubicin—testicular cancer	4.55e-05	0.000446	CcSEcCtD
Prednisone—Oedema—Doxorubicin—testicular cancer	4.55e-05	0.000446	CcSEcCtD
Prednisone—Fatigue—Methotrexate—testicular cancer	4.53e-05	0.000444	CcSEcCtD
Prednisone—Infection—Doxorubicin—testicular cancer	4.52e-05	0.000443	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Epirubicin—testicular cancer	4.48e-05	0.000439	CcSEcCtD
Prednisone—Shock—Doxorubicin—testicular cancer	4.47e-05	0.000439	CcSEcCtD
Prednisone—Nervous system disorder—Doxorubicin—testicular cancer	4.46e-05	0.000438	CcSEcCtD
Prednisone—Insomnia—Epirubicin—testicular cancer	4.44e-05	0.000436	CcSEcCtD
Prednisone—Tachycardia—Doxorubicin—testicular cancer	4.44e-05	0.000436	CcSEcCtD
Prednisone—Skin disorder—Doxorubicin—testicular cancer	4.42e-05	0.000434	CcSEcCtD
Prednisone—Paraesthesia—Epirubicin—testicular cancer	4.41e-05	0.000433	CcSEcCtD
Prednisone—Hyperhidrosis—Doxorubicin—testicular cancer	4.4e-05	0.000431	CcSEcCtD
Prednisone—Anorexia—Doxorubicin—testicular cancer	4.33e-05	0.000425	CcSEcCtD
Prednisone—Feeling abnormal—Methotrexate—testicular cancer	4.33e-05	0.000425	CcSEcCtD
Prednisone—Dyspepsia—Epirubicin—testicular cancer	4.33e-05	0.000425	CcSEcCtD
Prednisone—Gastrointestinal pain—Methotrexate—testicular cancer	4.29e-05	0.000421	CcSEcCtD
Prednisone—Decreased appetite—Epirubicin—testicular cancer	4.27e-05	0.000419	CcSEcCtD
Prednisone—Fatigue—Epirubicin—testicular cancer	4.24e-05	0.000416	CcSEcCtD
Prednisone—Constipation—Epirubicin—testicular cancer	4.2e-05	0.000413	CcSEcCtD
Prednisone—Urticaria—Methotrexate—testicular cancer	4.17e-05	0.000409	CcSEcCtD
Prednisone—Abdominal pain—Methotrexate—testicular cancer	4.15e-05	0.000407	CcSEcCtD
Prednisone—Body temperature increased—Methotrexate—testicular cancer	4.15e-05	0.000407	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	4.14e-05	0.000407	CcSEcCtD
Prednisone—Insomnia—Doxorubicin—testicular cancer	4.11e-05	0.000404	CcSEcCtD
Prednisone—Paraesthesia—Doxorubicin—testicular cancer	4.08e-05	0.000401	CcSEcCtD
Prednisone—Feeling abnormal—Epirubicin—testicular cancer	4.05e-05	0.000398	CcSEcCtD
Prednisone—Gastrointestinal pain—Epirubicin—testicular cancer	4.02e-05	0.000394	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—testicular cancer	4e-05	0.000393	CcSEcCtD
Prednisone—Decreased appetite—Doxorubicin—testicular cancer	3.95e-05	0.000388	CcSEcCtD
Prednisone—Fatigue—Doxorubicin—testicular cancer	3.92e-05	0.000385	CcSEcCtD
Prednisone—Urticaria—Epirubicin—testicular cancer	3.9e-05	0.000383	CcSEcCtD
Prednisone—Constipation—Doxorubicin—testicular cancer	3.89e-05	0.000382	CcSEcCtD
Prednisone—Abdominal pain—Epirubicin—testicular cancer	3.88e-05	0.000381	CcSEcCtD
Prednisone—Body temperature increased—Epirubicin—testicular cancer	3.88e-05	0.000381	CcSEcCtD
Prednisone—Hypersensitivity—Methotrexate—testicular cancer	3.87e-05	0.00038	CcSEcCtD
Prednisone—Asthenia—Methotrexate—testicular cancer	3.77e-05	0.00037	CcSEcCtD
Prednisone—Feeling abnormal—Doxorubicin—testicular cancer	3.75e-05	0.000368	CcSEcCtD
Prednisone—Gastrointestinal pain—Doxorubicin—testicular cancer	3.72e-05	0.000365	CcSEcCtD
Prednisone—Pruritus—Methotrexate—testicular cancer	3.71e-05	0.000365	CcSEcCtD
Prednisone—Hypersensitivity—Epirubicin—testicular cancer	3.62e-05	0.000355	CcSEcCtD
Prednisone—Urticaria—Doxorubicin—testicular cancer	3.61e-05	0.000355	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—testicular cancer	3.59e-05	0.000353	CcSEcCtD
Prednisone—Abdominal pain—Doxorubicin—testicular cancer	3.59e-05	0.000353	CcSEcCtD
Prednisone—Diarrhoea—Methotrexate—testicular cancer	3.59e-05	0.000353	CcSEcCtD
Prednisone—Asthenia—Epirubicin—testicular cancer	3.53e-05	0.000346	CcSEcCtD
Prednisone—Pruritus—Epirubicin—testicular cancer	3.48e-05	0.000341	CcSEcCtD
Prednisone—Dizziness—Methotrexate—testicular cancer	3.47e-05	0.000341	CcSEcCtD
Prednisone—Diarrhoea—Epirubicin—testicular cancer	3.36e-05	0.00033	CcSEcCtD
Prednisone—Hypersensitivity—Doxorubicin—testicular cancer	3.35e-05	0.000329	CcSEcCtD
Prednisone—Vomiting—Methotrexate—testicular cancer	3.34e-05	0.000328	CcSEcCtD
Prednisone—Rash—Methotrexate—testicular cancer	3.31e-05	0.000325	CcSEcCtD
Prednisone—Dermatitis—Methotrexate—testicular cancer	3.31e-05	0.000325	CcSEcCtD
Prednisone—Headache—Methotrexate—testicular cancer	3.29e-05	0.000323	CcSEcCtD
Prednisone—Asthenia—Doxorubicin—testicular cancer	3.26e-05	0.00032	CcSEcCtD
Prednisone—Dizziness—Epirubicin—testicular cancer	3.25e-05	0.000319	CcSEcCtD
Prednisone—Pruritus—Doxorubicin—testicular cancer	3.22e-05	0.000316	CcSEcCtD
Prednisone—Vomiting—Epirubicin—testicular cancer	3.12e-05	0.000307	CcSEcCtD
Prednisone—Nausea—Methotrexate—testicular cancer	3.12e-05	0.000306	CcSEcCtD
Prednisone—Diarrhoea—Doxorubicin—testicular cancer	3.11e-05	0.000305	CcSEcCtD
Prednisone—Rash—Epirubicin—testicular cancer	3.1e-05	0.000304	CcSEcCtD
Prednisone—Dermatitis—Epirubicin—testicular cancer	3.1e-05	0.000304	CcSEcCtD
Prednisone—Headache—Epirubicin—testicular cancer	3.08e-05	0.000302	CcSEcCtD
Prednisone—Dizziness—Doxorubicin—testicular cancer	3.01e-05	0.000295	CcSEcCtD
Prednisone—Nausea—Epirubicin—testicular cancer	2.92e-05	0.000287	CcSEcCtD
Prednisone—Vomiting—Doxorubicin—testicular cancer	2.89e-05	0.000284	CcSEcCtD
Prednisone—Rash—Doxorubicin—testicular cancer	2.87e-05	0.000281	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—testicular cancer	2.86e-05	0.000281	CcSEcCtD
Prednisone—Headache—Doxorubicin—testicular cancer	2.85e-05	0.00028	CcSEcCtD
Prednisone—Nausea—Doxorubicin—testicular cancer	2.7e-05	0.000265	CcSEcCtD
